O-24 - Hot Issues in Clinical Practice

Co-Author(s)

• 

  Rima Abdel-Massih, MD

  Assistant Professor of Medicine
  University of Pittsburgh
  Pittsburgh, Pennsylvania

  Disclosure: Infectious Disease Connect : Chief Medical Officer (Status: Ongoing), Other Financial or Material Support (Status: Ongoing), Other Financial or Material Support (Status: Ongoing), Shareholder (Status: Ongoing)
• 

  Bryan Alexander, PharmD

  ID Clinical Pharmacist, OPAT Pharmacy Coordinator
  Nebraska Medicine
  Omaha, Nebraska

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• SB

  Scott Bergman, PharmD, FCCP, FIDSA, BCPS

  Pharmacist- Antimicrobial Stewardship Coordinator
  Department of Pharmaceutical and Nutrition Care
  Nebraska Medicine
  Omaha, Nebraska

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• NC

  Nicolas Cortes-Penfield, MD

  Assistant Professor
  Infectious Diseases
  University of Nebraska Medical Center
  Omaha, Nebraska

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AD

  Alyse Douglass, RN

  Registered Nurse
  Department of Medicine, Division of Infectious Diseases
  Oregon Health and Sciences University
  Portland, Oregon

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MJ

  Mamta Jaiswal, PhD

  Senior Research Analyst
  STATinMED Research, Ann Arbor, MI, USA
  Ann Arbor, Michigan

  Disclosure: GlaxoSmithKline plc. (Other Financial or Material Support, Funding)STATinMED Research (Employee)
• AJ

  Ashish Joshi, PhD

  Senior Director
  GlaxoSmithKline plc, Collegeville, PA, USA
  Philadelphia, Pennsylvania

  Disclosure: GlaxoSmithKline plc.: Employee, Shareholder
• JL

  James Lewis, PharmD

  Infectious Disease Pharmacist
  Oregon Health and Science University
  Portland, Oregon

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• TL

  Ted Louie, M.D.

  M.D.
  University of Rochester
  Rochester, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• SL

  Strnad Luke, MD

  Assistant Professor of Medicine
  Oregon Health and Science University and Portland State University School of Public Health
  Portland, Oregon

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• CL

  Christina Lupone, MPH

  Instructor
  State University of New York Upstate
  Syracuse, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JM

  Jina Makadia, MD

  Infectious Diseases Physician
  Oregon Health and Science University
  Portland, Oregon

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• Rm

  Rupinder mangat, M.D.

  M.D.
  Infectious diseaseses
  University of Rochester
  Rochester, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• HM

  Heather Mayer, RN

  Registered Nurse
  Department of Medicine, Division of Infectious Diseases
  Oregon Health and Sciences University
  Portland, Oregon

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JM

  John Mellors, MD

  Professor of Medicine
  University of Pittsburgh
  Pittsburgh, Pennsylvania

  Disclosure: Abound Bio (Shareholder)Accelevir Diagnostics (Consultant)Co-Crystal Pharmaceuticals (Shareholder)Gilead (Consultant, Grant/Research Support)Merck (Consultant)
• FM

  Fanny Mitrani-Gold, MPH

  Director, Epidemiology
  GlaxoSmithKline plc, Collegeville, PA, USA
  Chicago, Illinois

  Disclosure: GlaxoSmithKline plc. (Employee, Shareholder)
• KP

  Kristopher Paolino, MD, MTM&H

  Assistant Professor
  State University of New York Upstate Medical University
  Syracuse, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• PP

  Prishanya Pillai, MD

  M.D.
  Internal medicine
  Universitty of Rochester
  Rochester, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AS

  Adit Sanghvi, MISM

  Senior Machine Learning Engineer
  UPMC Enterprises
  Pittsburgh, Pennsylvania

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Monica Sikka, MD

  Assistant Professor of Medicine
  Division of Infectious Diseases
  Oregon Health & Science University
  Portland, Oregon

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• ES

  Ellie Sukerman, MD

  Assistant Professor of Medicine, Division of Infectious Diseases
  Oregon Health & Science University
  Portland, Oregon

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• XS

  Xiaoxi Sun, MA

  Senior Statistical Programmer
  STATinMED Research, Ann Arbor, MI, USA
  Ann Arbor, Michigan

  Disclosure: GlaxoSmithKline plc. (Other Financial or Material Support, Funding)STATinMED Research (Employee)
• 

  Trevor Van Schooneveld, MD, FACP

  Associate Professor, Division of Infectious Diseases
  Internal Medicine
  University of Nebraska Medical Center
  Omaha, Nebraska

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AW

  Adam Wegman, BS

  MD/PhD Student
  Microbiology and Immunology
  State University of New York Upstate Medical University
  Syracuse, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AW

  Angelina Winbush, B.S

  B.S.
  Medicine
  University of Rochester
  Rochester, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• LX

  Lin Xie, MS, MA

  Vice President
  STATinMED Research, Ann Arbor, MI, USA
  Raleigh, North Carolina

  Disclosure: GlaxoSmithKline plc. (Other Financial or Material Support, Funding)STATinMED Research (Employee)
• KY

  Kathleen Young, RN

  Registered Nurse
  Department of Medicine, Division of Infectious Diseases
  Oregon Health and Sciences University
  Portland, Oregon

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presenting Author(s)

• 

  Karen Carvajal, MD

  Infectious Diseases Fellow
  Infectious diseases
  University of Rochester
  Rochester, NY

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Ivayla Geneva, MD,PhD

  Fellow
  State University of New York Upstate
  Syracuse, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Nupur Gupta, DO

  Clinical Assistant Professor
  Division of Infectious Diseases
  University of Pittsburgh Medical Center
  Pittsburgh, Pennsylvania

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Amber Streifel, PharmD, BCPS

  Infectious Diseases Pharmacist
  Department of Pharmacy Services
  Oregon Health & Science University
  Portland, OR

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Yuexi Wang, M.Econ

  Director
  STATinMED Research, Ann Arbor, MI, USA
  Ann Arbor, Michigan

  Disclosure: GlaxoSmithKline plc.: Funding, Other Financial or Material Support; STATinMED Research: Employee

  Slides Slides and Audio
• 

  Brett Young, PharmD

  Pharmacist Resident
  Nebraska Medicine
  Omaha, NE

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio

Presentations:

• Dalbavancin Use in Patients with Substance Use Disorders
  Amber C. Streifel, PharmD, BCPS – Oregon Health & Science University; Jina Makadia, MD – Oregon Health and Science University; Strnad Luke, MD – Oregon Health and Science University and Portland State University School of Public Health; Alyse Douglass, RN – Oregon Health and Sciences University; Heather Mayer, RN – Oregon Health and Sciences University; Kathleen Young, RN – Oregon Health and Sciences University; James Lewis, PharmD – Oregon Health and Science University; Ellie Sukerman, MD – Oregon Health & Science University; Monica K. Sikka, MD – Oregon Health & Science University
• Treatment Patterns and Prevalence of Inappropriate and Suboptimal Antibiotic Use Among Females with Uncomplicated Urinary Tract Infection in the US
  Yuexi Wang, M.Econ – STATinMED Research, Ann Arbor, MI, USA; Fanny S. Mitrani-Gold, MPH – GlaxoSmithKline plc, Collegeville, PA, USA; Lin Xie, MS, MA – STATinMED Research, Ann Arbor, MI, USA; Mamta Jaiswal, PhD – STATinMED Research, Ann Arbor, MI, USA; Xiaoxi Sun, MA – STATinMED Research, Ann Arbor, MI, USA; Ashish V. Joshi, PhD – GlaxoSmithKline plc, Collegeville, PA, USA
• Six-year Longitudinal Analysis of an Inpatient Infectious Diseases Telemedicine Service at a Community Hospital
  Nupur Gupta, DO – University of Pittsburgh Medical Center; Adit B. Sanghvi, MISM – UPMC Enterprises; John Mellors, MD – University of Pittsburgh; Rima Abdel-Massih, MD – University of Pittsburgh
• Effect of Body Temperature Before Hospital Discharge on the Readmission Rate
  Ivayla I. Geneva, MD,PhD – State University of New York Upstate; Christina Lupone, MPH – State University of New York Upstate; Adam D. Wegman, BS – State University of New York Upstate Medical University; Kristopher M. Paolino, MD, MTM&H – State University of New York Upstate Medical University
• evaluation of Addition of Outpatient Parenteral Antimicrobial Therapy and Orthopedic ID Resources to Transitions-of-care Outcomes
  Brett Young, PharmD – Nebraska Medicine; Scott Bergman, PharmD, FCCP, FIDSA, BCPS – Nebraska Medicine; Trevor C. Van Schooneveld, MD, FACP – University of Nebraska Medical Center; Nicolas W. Cortes-Penfield, MD – University of Nebraska Medical Center; Bryan Alexander, PharmD – Nebraska Medicine
• walking to the Virtual Era. Analysis of the Telehealth Experience in the Infectious Diseases Clinic During the COVID Pandemic.
  Karen L. Carvajal, MD – University of Rochester; Prishanya Pillai, MD – Universitty of Rochester; Angelina Winbush, B.S – University of Rochester; Rupinder mangat, M.D. – University of Rochester; Ted Louie, M.D. – University of Rochester